MARKET

MBIO

MBIO

Mustang Bio
NASDAQ
2.870
-0.030
-1.03%
After Hours: 2.770 -0.1 -3.48% 16:10 02/12 EST
OPEN
2.950
PREV CLOSE
2.900
HIGH
2.965
LOW
2.710
VOLUME
155.51K
TURNOVER
--
52 WEEK HIGH
74.50
52 WEEK LOW
2.605
MARKET CAP
3.72M
P/E (TTM)
-1.6746
1D
5D
1M
3M
1Y
5Y
1D
Mustang Bio regains compliance with Nasdaq
TipRanks · 1d ago
MUSTANG BIO REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
Reuters · 1d ago
MUSTANG BIO ANNOUNCES CLOSING OF $8 MILLION PUBLIC OFFERING
Reuters · 2d ago
Weekly Report: what happened at MBIO last week (0203-0207)?
Weekly Report · 2d ago
Mustang Bio Reports Pricing Of $8M Public Offering
Benzinga · 6d ago
Mustang Bio prices 2.66M shares at $3.01 in public offering
TipRanks · 6d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 6d ago
MUSTANG BIO ANNOUNCES PRICING OF $8 MILLION PUBLIC OFFERING
Reuters · 6d ago
More
About MBIO
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for cancers and rare genetic diseases. The Company has partnered with medical institutions to advance the development of chimeric antigen receptor modified T cell (CAR-T) therapies across multiple cancers, as well as lentiviral gene therapies for severe combined immunodeficiency. Its pipeline is focused in three core areas: CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors and gene therapies for rare genetic disorders. It is developing a CAR T therapy for hematologic malignancies in partnership with Fred Hutch targeting CD20 (MB-106). In partnership with St. Jude, its X-linked Severe Combined Immunodeficiency (XSCID) gene therapy programs (MB-117 and MB-217) are being developed under an exclusive license to develop a potentially curative treatment for XSCID, a rare genetic immune system condition.

Webull offers Mustang Bio Inc stock information, including NASDAQ: MBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBIO stock methods without spending real money on the virtual paper trading platform.